Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
5
Frequently Asked Questions
What is Market Cap of Anixa Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Anixa Biosciences Inc market cap is $94.54M.
What is the 52-week high for Anixa Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Anixa Biosciences Inc 52 week high is $4.20 as of September 13, 2025.
What is the 52-week low for Anixa Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Anixa Biosciences Inc 52 week low is $2.07 as of September 13, 2025.
What is Anixa Biosciences Inc stock price today?
Anixa Biosciences Inc stock price today is $2.94.
What was Anixa Biosciences Inc stock price yesterday?
Anixa Biosciences Inc stock price yesterday was $2.95.
What is the PE ratio of Anixa Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Anixa Biosciences Inc’s P/E ratio is -8.52.
What is the Price-to-Book ratio of Anixa Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Anixa Biosciences Inc P/B ratio is 5.8050.
What is the 50-day moving average of Anixa Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Anixa Biosciences Inc 50-day moving average is $3.10.
How many employess does Anixa Biosciences Inc has?
